India’s COVID-19 count approaches 90-Lakh Mark after 45,576 cases in one day

0
7
->

India coronavirus case: India reported less than 50,000 cases for 12th consecutive day

New Delhi:

India’s COVID-19 tally has approached the 90 lakh mark with 45,576 confirmed cases on Thursday, according to the Union Ministry of Health and Family.

The country’s total of Covid-19 has risen to 89,58,484 including 83,83,602 recoveries and 4,43,303 active cases. With 585 new deaths, the cumulative number has increased to 1,31,578.

This is the twelfth day in a row India has reported less than 50,000 cases per day. The last time new daily cases crossed the 50,000-person threshold was on November 7.

New recoveries continue to outpace new daily cases continuously for the past 47 days. India’s active workload fell below 5% today, according to an official press release.

Here are the live updates on the coronavirus cases:

Pfizer to seek approval for emergency vaccine in the United States on Friday
An emergency use authorization application for the Covid-19 vaccine developed by Pfizer and BioNTech is expected to be filed with the FDA on Friday, the U.S. government and BioNTech co-founder said.

This type of clearance from the Food and Drug Administration is temporary or conditional and is granted in response to an emergency such as a pandemic.

“BioNTech, partner of Pfizer, has announced its intention to file an emergency use authorization with the FDA tomorrow,” Health Secretary Alex Azar said at a press conference Thursday in Washington.

BioNTech co-founder Ugur Sahin told AFP in an interview with Zoom: “The documents will be finalized today and tomorrow and submitted to the FDA.”

The FDA did not say how long it would take to review the data on vaccine efficacy and safety, the two main criteria.

COVID-19: Andhra reports 1,316 new cases

Andhra Pradesh has reported 1,316 new cases of COVID-19, bringing the total to 8.58,711, the state government said on Thursday.

According to the state government, total recoveries in the state stand at 835,801, with 1,821 people recovered in the last 24 hours.

The death toll has reached 6,911 in the state with eleven people succumbing to the disease. Of the eleven deaths reported today, two people have died each in Chittoor and Krishna districts while one death has been reported in Anantapur, East Godavari, Guntur, Nellore, Srikakulam, Visakhapatnam and West Godavari districts.

Coronavirus News: Joe Biden says not to order ‘national shutdown’ despite Covid surge

US President-elect Joe Biden said on Thursday that he would not order a nationwide shutdown to tackle the Covid-19 pandemic despite an increase in the number of cases.

States and cities have imposed their own restrictions, including house arrest, the closure of indoor restaurants and a limit on gatherings as infections soar across the country.

“There are no circumstances that I can see that would require a total nationwide shutdown. I think that would be counterproductive,” said Biden, who takes office on Jan. 20.

He said, however, that the rules for when and how businesses and other establishments can open should be calibrated according to the threat in the area in question, noting the different levels of spread across the country.

COVID-19: WHO advises against remdesivir for treatment of coronavirus
Remdesivir, an antiviral drug, should not be used to treat patients with Covid-19, regardless of the severity of their illness, as it has “no significant effect” on the chances of survival, said Friday the World Health Organization.

Aside from one of the few treatments that had shown some initial promise in severe patients, a WHO Guidelines Development Group (GDG) of international experts said there was “no evidence based on currently available data indicating that it improves important patient outcomes.

The United States, the European Union and other countries have granted temporary authorization for the use of remdesivir after initial research showed that it may shorten the recovery time in some patients with coronavirus.

LEAVE A REPLY

Please enter your comment!
Please enter your name here